Table 1.
Subgroups | Baseline | 3 months of 5-FU therapy | 6 months of 5-FU therapy | P-value | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|
miRNA223-3p | |||||||||||
ERK | ≤ 0.92 | 6.22 | 5.65 | 6.39 | 5.52 | 4.24 | 6.12 | 5.82 | 5.39 | 6.39 | 0.247 |
> 0.92 | 6.07 | 5.77 | 6.76 | 5.2 | 4.65 | 5.82 | 6.32 | 5.34 | 7.08 | 0.031 | |
P-value | 0.121 | 0.895 | 0.303 | ||||||||
PTEN | ≤ 1407.85 | 6.28 | 5.94 | 6.57 | 5.52 | 3.51 | 6.41 | 5.82 | 5.09 | 6.39 | 0.344 |
> 1407.85 | 6.07 | 5.65 | 6.39 | 5.38 | 4.65 | 5.55 | 6.32 | 5.52 | 7.08 | 0.011 | |
P-value | 0.119 | 0.885 | 0.228 | ||||||||
EGFR | ≤ 6.53 | 6.28 | 5.74 | 6.57 | 5.49 | 4.24 | 6.41 | 6 | 5.39 | 6.89 | 0.247 |
> 6.53 | 6.19 | 5.81 | 6.55 | 5.2 | 4.65 | 5.82 | 6.05 | 5.34 | 6.71 | 0.038 | |
P-value | 0.12 | 0.728 | 0.915 | ||||||||
miRNA20a-5p | |||||||||||
ERK | ≤ 0.92 | 4.74 | 4.19 | 6.01 | 4.29 | 3.47 | 5.13 | 4.62 | 4.05 | 5.43 | 0.766 |
> 0.92 | 4.66 | 4.34 | 5.22 | 4.42 | 3.6 | 4.74 | 5.07 | 4.52 | 6.21 | 0.155 | |
P-value | 0.121 | 0.057 | 0.707 | 0.364 | |||||||
PTEN | ≤ 1407.85 | 4.52 | 4.1 | 6.01 | 4.42 | 3.47 | 5.13 | 4.62 | 4.13 | 5.61 | 0.936 |
> 1407.85 | 4.87 | 4.59 | 5.77 | 4.3 | 3.6 | 4.74 | 5.07 | 4.05 | 6.02 | 0.085 | |
P-value | 0.119 | 0.036 | 0.675 | 0.812 | |||||||
EGFR | ≤ 6.53 | 4.74 | 4.19 | 6.01 | 4.29 | 3.47 | 5.13 | 4.62 | 4.05 | 5.43 | 0.766 |
> 6.53 | 4.66 | 4.34 | 5.22 | 4.42 | 3.6 | 4.74 | 5.07 | 4.52 | 6.21 | 0.155 | |
P-value | 0.12 | 0.057 | 0.707 | 0.364 | |||||||
miRNA19a-3p | |||||||||||
ERK | ≤ 0.92 | 3.53 | 2.23 | 4.45 | 2.78 | 1.57 | 3.52 | 3.63 | 3.29 | 4.63 | 0.165 |
> 0.92 | 4.18 | 3.54 | 5 | 2.58 | 1.76 | 3.72 | 4.26 | 3.1 | 4.98 | 0.007 | |
P-value | 0.121 | 0.018 | 0.757 | 0.669 | |||||||
PTEN | ≤ 1407.85 | 3.53 | 2.82 | 4.6 | 2.81 | 1.43 | 3.92 | 3.59 | 3.27 | 4.6 | 0.42 |
> 1407.85 | 3.77 | 2.91 | 4.35 | 2.58 | 2.06 | 3.72 | 4.26 | 3.34 | 4.98 | 0.005 | |
P-value | 0.119 | 0.101 | 0.73 | ||||||||
EGFR | ≤ 6.53 | 3.53 | 2.84 | 4.6 | 2.81 | 1.55 | 3.92 | 3.63 | 3.29 | 4.63 | 0.42 |
> 6.53 | 3.87 | 2.91 | 4.35 | 2.47 | 1.8 | 3.17 | 3.94 | 3.24 | 4.8 | 0.005 | |
P-value | 0.12 | 0.09 | 0.696 | 0.768 | |||||||
miRNA17-5p | |||||||||||
ERK | ≤ 0.92 | 3.3 | 3.09 | 3.89 | 3.37 | 2.72 | 4.19 | 3.49 | 3.09 | 4.38 | 0.819 |
> 0.92 | 4.15 | 3.61 | 4.89 | 3.31 | 2.47 | 3.76 | 3.95 | 2.9 | 5.06 | 0.041 | |
P-value | 0.121 | 0.009 | 0.646 | 0.448 | |||||||
PTEN | ≤ 1407.85 | 3.62 | 3.11 | 4.89 | 3.16 | 2.49 | 4.19 | 3.46 | 2.97 | 4.38 | 0.936 |
> 1407.85 | 3.7 | 3.29 | 4.66 | 3.41 | 2.66 | 3.59 | 3.95 | 3.51 | 5.06 | 0.127 | |
P-value | 0.119 | 0.062 | 0.744 | 0.212 | |||||||
EGFR | ≤ 6.53 | 3.35 | 3.11 | 4.89 | 3.37 | 2.49 | 4.19 | 3.49 | 3.09 | 4.58 | 1 |
> 6.53 | 3.74 | 3.48 | 4.76 | 3.31 | 2.66 | 3.59 | 3.95 | 2.97 | 4.89 | 0.074 | |
P-value | 0.12 | 0.043 | 0.679 | 0.647 | |||||||
miRNA7-5p | |||||||||||
ERK | ≤ 0.92 | 1.23 | − 0.17 | 1.73 | 0.61 | − 0.23 | 1.38 | 0.55 | 0.44 | 1.48 | 1 |
> 0.92 | 1.25 | 0.94 | 2.16 | 0.42 | − 0.34 | 1.01 | 1.31 | 0.84 | 2.46 | 0.011 | |
P-value | 0.121 | < 0.001 | 0.435 | 0.277 | |||||||
PTEN | ≤ 1407.85 | 1.45 | − 0.09 | 2.2 | 0.13 | − 0.45 | 1.38 | 1.17 | 0.44 | 1.48 | 0.549 |
> 1407.85 | 1.21 | 0.92 | 1.91 | 0.47 | 0.06 | 1.09 | 1.08 | 0.74 | 2.48 | 0.155 | |
P-value | 0.119 | 0.002 | 0.628 | 0.49 | |||||||
EGFR | ≤ 6.53 | 1.41 | − 0.09 | 2.2 | 0.47 | − 0.34 | 1.36 | 1.19 | 0.44 | 1.64 | 0.766 |
> 6.53 | 1.23 | 0.92 | 1.91 | 0.43 | − 0.01 | 1.01 | 1.08 | 0.74 | 2.21 | 0.038 | |
P-value | 0.12 | 0.001 | 0.595 | 0.736 |
Data presented as medians and IQR of miRNAs level. Significant P-values ≤ 0.01 are displayed in bold- italic font.
IQR interquartile range.